A heterozygous effect for PINK1 mutations in Parkinson's disease?-Reference-Cited by-同舟云学术

A heterozygous effect for PINK1 mutations in Parkinson's disease?

Published:2006-09-12 Issue:4 Volume:60 Page:414-419
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Abou-Sleiman Patrick M.,Muqit Miratul M. K.,McDonald Neil Q.,Yang Yan Xiang,Gandhi Sonia,Healy Daniel G.,Harvey Kirsten,Harvey Robert J.,Deas Emma,Bhatia Kailash,Quinn Niall,Lees Andrew,Latchman David S.,Wood Nicholas W.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference17 articles.

1. Expanding insights of mitochondrial dysfunction in Parkinson's disease;Abou-Sleiman;Nat Rev Neurosci,2006

2. Hereditary early-onset Parkinson's disease caused by mutations in PINK1;Valent;Science,2004

3. Enhanced genome annotation using structural profiles in the program 3D-PSSM;Kelley;J Mol Biol,2000

4. Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM;Bates;Proteins,2001

5. PINK1 mutations are associated with sporadic early-onset parkinsonism;Valente;Ann Neurol,2004

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PINK1-G411S mutant increases kinase stability and enhances mitochondrial-linked functions;2024-07-01

2. FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis;Acta Pharmaceutica Sinica B;2023-12

3. Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease;Pharmaceutics;2023-03-03

4. Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming;Cellular Reprogramming;2022-10-01

5. Systematic Functional Analysis of PINK1 and PRKN Coding Variants;Cells;2022-08-05